Single and Repeat Doses of DMT in Healthy Subjects
Clinical trial NCT05559931 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05559931
- Sponsor
- Algernon Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-13
- Primary completion
- 2026-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.